Cellebrite DI Ltd
NASDAQ:CLBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (25.1), the stock would be worth $18.8 (48% upside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16.9 | $12.68 |
0%
|
| 3-Year Average | 25.1 | $18.8 |
+48%
|
| 5-Year Average | 27.1 | $20.31 |
+60%
|
| Industry Average | 16.6 | $12.46 |
-2%
|
| Country Average | 19 | $14.2 |
+12%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| IL |
|
Cellebrite DI Ltd
NASDAQ:CLBT
|
3.1B USD | 16.9 | 40.5 | |
| US |
|
Ezenia! Inc
OTC:EZEN
|
567B USD | -152 953.6 | -180 630.8 | |
| US |
|
Palantir Technologies Inc
NASDAQ:PLTR
|
336.5B USD | 156.6 | 206.6 | |
| DE |
|
SAP SE
XETRA:SAP
|
173.8B EUR | 20.2 | 24.3 | |
| US |
|
Salesforce Inc
NYSE:CRM
|
169.9B USD | 11.9 | 22.8 | |
| US |
|
Applovin Corp
NASDAQ:APP
|
151.9B USD | 38.1 | 45.6 | |
| US |
|
Intuit Inc
NASDAQ:INTU
|
111.1B USD | 16.5 | 25.5 | |
| US |
|
Adobe Inc
NASDAQ:ADBE
|
98.7B USD | 9.3 | 13.7 | |
| US |
|
Synopsys Inc
NASDAQ:SNPS
|
95.4B USD | -7 | 84.1 | |
| US |
N
|
NCR Corp
LSE:0K45
|
92B USD | -247.7 | 2 191 | |
| US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
88.4B USD | 56 | 79.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10.8 |
| Median | 19 |
| 70th Percentile | 32.9 |
| Max | 7 310 |
Other Multiples
Cellebrite DI Ltd
Glance View
Cellebrite DI Ltd. has carved a niche for itself in the digital intelligence arena, becoming a beacon for law enforcement and government agencies worldwide. Born in Petah Tikva, Israel, the company began its journey focusing on mobile data transfer technology before pivoting to one of the most critical aspects of modern policing—extracting and analyzing data from digital devices. Cellebrite's flagship product, the Universal Forensic Extraction Device (UFED), allows investigators to retrieve a plethora of data from smartphones, tablets, and other devices. This capability is crucial in solving crimes, making Cellebrite an indispensable partner for agencies tackling everything from cybercrime to terrorism. The company’s business model thrives on providing not just the hardware and software tools but also ongoing support and training services. This creates a steady stream of recurring revenue, as agencies continually rely on Cellebrite for updates in response to the ever-evolving digital landscape. Additionally, their subscription-based offerings grant clients access to the latest forensic advancements, embedding Cellebrite deeper into their operational frameworks. By focusing on combining comprehensive data solutions with robust client support, Cellebrite ensures its position as a leader in the digital intelligence domain, weaving its technology into the very fabric of modern investigative processes.
